Company intelligence / Profile preview

Plasmacure

Eindhoven, North Brabant, Netherlandsplasmacure.nl ↗

Ownership: Private
Development stage: Other

Overview

The PLASOMA cold plasma system has demonstrated strong clinical results, healing complex wounds up to 2.5 times more effectively than standard care. It has received CE marking and European funding, with initial clinical studies showing promising outcomes for chronic wound healing. U.S. commercialization awaits FDA approval.

Therapeutic areas: DermatologyEndocrinologyOther
Modalities: DeviceNon-pharmacological therapy (cold plasma)
Industry: Therapeutic Medical Devices

Partnerships

Venture Medical LLC – exclusive U.S. commercialization partner for the PLASOMA device; leading FDA process and distribution efforts in the United States.

Beyond the preview

Go deeper on Plasmacure.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmacure.

Explore the full profile